Kato Y - Search Results

1

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation.

Kato Y, Jin G, Kuan CT, McLendon RE, Yan H, Bigner DD. Kato Y, et al. Biochem Biophys Res Commun. 2009 Dec 18;390(3):547-51. doi: 10.1016/j.bbrc.2009.10.001. Epub 2009 Oct 7. Biochem Biophys Res Commun. 2009. PMID: 19818334 Free PMC article.

2

Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain.

Kato Y, Kaneko MK, Kuno A, Uchiyama N, Amano K, Chiba Y, Hasegawa Y, Hirabayashi J, Narimatsu H, Mishima K, Osawa M. Kato Y, et al. Biochem Biophys Res Commun. 2006 Nov 3;349(4):1301-7. doi: 10.1016/j.bbrc.2006.08.171. Epub 2006 Sep 7. Biochem Biophys Res Commun. 2006. PMID: 16979138

3

GMab-1, a high-affinity anti-3'-isoLM1/3',6'-isoLD1 IgG monoclonal antibody, raised in lacto-series ganglioside-defective knockout mice.

Kato Y, Kuan CT, Chang J, Kaneko MK, Ayriss J, Piao H, Chandramohan V, Pegram C, McLendon RE, Fredman P, Månsson JE, Bigner DD. Kato Y, et al. Biochem Biophys Res Commun. 2010 Jan 1;391(1):750-5. doi: 10.1016/j.bbrc.2009.11.132. Epub 2009 Nov 26. Biochem Biophys Res Commun. 2010. PMID: 19944071 Free PMC article.

4

Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas.

Kato Y, Vaidyanathan G, Kaneko MK, Mishima K, Srivastava N, Chandramohan V, Pegram C, Keir ST, Kuan CT, Bigner DD, Zalutsky MR. Kato Y, et al. Nucl Med Biol. 2010 Oct;37(7):785-94. doi: 10.1016/j.nucmedbio.2010.03.010. Nucl Med Biol. 2010. PMID: 20870153 Free PMC article.

5

Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation.

Kaneko MK, Tian W, Takano S, Suzuki H, Sawa Y, Hozumi Y, Goto K, Yamazaki K, Kitanaka C, Kato Y. Kaneko MK, et al. Among authors: kato y. Biochem Biophys Res Commun. 2011 Mar 25;406(4):608-13. doi: 10.1016/j.bbrc.2011.02.102. Epub 2011 Feb 23. Biochem Biophys Res Commun. 2011. PMID: 21352804

6

Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors.

Chandramohan V, Bao X, Kato Kaneko M, Kato Y, Keir ST, Szafranski SE, Kuan CT, Pastan IH, Bigner DD. Chandramohan V, et al. Among authors: kato kaneko m, kato y. Int J Cancer. 2013 May 15;132(10):2339-48. doi: 10.1002/ijc.27919. Epub 2012 Nov 23. Int J Cancer. 2013. PMID: 23115013 Free PMC article.

7

Establishment of novel monoclonal antibodies KMab-1 and MMab-1 specific for IDH2 mutations.

Kaneko MK, Morita S, Tsujimoto Y, Yanagiya R, Nasu K, Sasaki H, Hozumi Y, Goto K, Natsume A, Watanabe M, Kumabe T, Takano S, Kato Y. Kaneko MK, et al. Among authors: kato y. Biochem Biophys Res Commun. 2013 Mar 1;432(1):40-5. doi: 10.1016/j.bbrc.2013.01.088. Epub 2013 Jan 31. Biochem Biophys Res Commun. 2013. PMID: 23376717

8

A novel monoclonal antibody GMab-m1 specifically recognizes IDH1-R132G mutation.

Kato Y, Natsume A, Kaneko MK. Kato Y, et al. Biochem Biophys Res Commun. 2013 Mar 22;432(4):564-7. doi: 10.1016/j.bbrc.2013.02.049. Epub 2013 Feb 26. Biochem Biophys Res Commun. 2013. PMID: 23485467

9

Generation of a novel monoclonal antibody WMab-1 specific for IDH2-R172W mutation.

Kato Y, Kaneko MK. Kato Y, et al. Biochem Biophys Res Commun. 2013 Apr 19;433(4):374-8. doi: 10.1016/j.bbrc.2013.02.106. Epub 2013 Mar 20. Biochem Biophys Res Commun. 2013. PMID: 23524262

10

Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas.

Kato Y. Kato Y. Brain Tumor Pathol. 2015 Jan;32(1):3-11. doi: 10.1007/s10014-014-0202-4. Epub 2014 Oct 17. Brain Tumor Pathol. 2015. PMID: 25324168 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,751 results

Search Page

Filters